Related Experiment Video
Updated: Feb 10, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
Adjuvant immunotherapy for solid tumors: from promise to clinical application
Simone Mocellin1, Carlo R Rossi, Mario Lise
1Department of Oncological and Surgical Sciences, Institute of Clinical Surgery II, 6 Piano Policlinico Uviversitario, Via Giustiniani 2, University of Padua, Padua, Italy.
Adjuvant immunotherapy shows promise for eradicating microscopic residual disease after surgery for solid tumors. This approach leverages the immune system to target cancer cells, offering a new strategy beyond traditional chemotherapy.
Area of Science:
- Oncology
- Immunology
- Cancer Research
Background:
- Surgery is the primary treatment for solid tumors, but microscopic residual disease often leads to relapse.
- Adjuvant chemotherapy offers benefits but struggles to control minimal residual disease effectively.
- Immunotherapy presents a promising novel approach to complement existing cancer treatments.
Purpose of the Study:
- To review immunological strategies for adjuvant immunotherapy in solid tumors.
- To report global clinical results of adjuvant immunotherapy applications.
- To explore immunotherapy's potential in eradicating microscopic disease post-surgery.
Main Methods:
- Review of clinical studies and worldwide results of adjuvant immunotherapy for solid tumors.
- Identification of immunogenic tumor antigens for targeted immune responses.
- Evaluation of immunotherapy in the adjuvant setting based on responses in metastatic disease.
Main Results:
- Immunotherapy strategies have been explored in human clinical trials for solid tumors.
- Clinical responses observed in patients with metastatic disease have prompted adjuvant setting evaluations.
- Ongoing research focuses on harnessing the host immune system against residual cancer cells.
Conclusions:
- Adjuvant immunotherapy is a developing strategy to address microscopic residual disease after solid tumor surgery.
- Advances in tumor immunology and antigen identification are crucial for effective immunotherapy.
- Further clinical application and research are needed to optimize adjuvant immunotherapy outcomes.
Related Concept Videos
Tumor Immunotherapy
Clinical Applications of Epidermal Stem Cells
Metallic Solids
All metallic solids exhibit high thermal and electrical conductivity, metallic luster, and malleability....
Structures of Solids
Local Anesthetics: Clinical Application as Spinal Anesthesia
Local Anesthetics: Clinical Application as Epidural Anesthesia
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...

